Morningstar

Eli Lilly on Track for Record High Close — Data Talk

Provided by Dow Jones

Eli Lilly and Company (LLY) is currently at $1298.40, up $58.06 or 4.68% 




       --Would be new all-time closing high (Based on available data back to July 18, 1972) 



       --Would be the first record closing high since Aug. 19, 2026, when it closed at $1,280.34 



       --On pace for largest percent increase since Aug. 5, 2026, when it rose 4.86% 



       --Currently up four of the past five days 



       --Up 12.21% month-to-date 



       --Up 20.82% year-to-date 



       --Up 62.39% from 52 weeks ago (Oct. 21, 2025), when it closed at $799.57 



       --Would be a new 52-week closing high 



       --Up 62.39% from its 52-week closing low of $799.57 on Oct. 21, 2025 



       --Traded as high as $1311.75; new all-time intraday high (Based on available data back to July 18, 1972) 



       --Up 5.76% at today's intraday high; largest intraday percent increase since Aug. 5, 2026, when it rose as much as 9.08% 



       --Sixth best performer in the S&P 500 today 





     All data as of 11:38:47 AM ET 





     Source: Dow Jones Market Data, FactSet 





  (END) Dow Jones Newswires



  October 20, 2026 11:56 ET (15:56 GMT)


Copyright (c) 2026 Dow Jones & Company, Inc.
  

					The articles, information, and content displayed on this webpage may
					include materials prepared and provided by third parties. Such
					third-party content is offered for informational purposes only and
					is not endorsed, reviewed, or verified by Morningstar.
				
 

					Morningstar makes no representations or warranties regarding the
					accuracy, completeness, timeliness, or reliability of any third-party
					content displayed on this site. The views and opinions expressed in
					third-party content are those of the respective authors and do not
					necessarily reflect the views of Morningstar, its affiliates, or employees.
				
 

					Morningstar is not responsible for any errors, omissions, or delays
					in this content, nor for any actions taken in reliance thereon.
					Users are advised to exercise their own judgment and seek independent
					financial advice before making any decisions based on such content.
					The third-party providers of this content are not affiliated with
					Morningstar, and their inclusion on this site does not imply any
					form of partnership, agency, or endorsement.
				
 

				Popular
				
 
  
 
 
 
 
4 Stocks to Buy for the Long-Term While They’re Still Undervalued
 
Plus, a deep dive on SpaceX’s bid to challenge US telecoms. 
 
 
David Sekera, CFA and Sarah Hansen 
 
 
 
Are TIPS ETFs the Best Way to Fight Inflation?
 
Plus, four TIPS ETFs with top marks from Morningstar, and what you need to know before investing. 
 
 
Daniel Sotiroff and Ivanna Hampton 
 
 
 
What’s Ahead for Stocks This Quarter—and Where to Invest
 
Morningstar’s chief market strategist and economist share their outlooks for the fourth quarter of 2026. 
 
 
David Sekera, CFA, Preston Caldwell, and Susan Dziubinski 
 
 
 
10 Best Blue-Chip Stocks to Buy for the Long Term
 
The stocks of these high-quality companies look cheap today. 
 
 
Tori Brovet 
 
 
 
6 ETFs To Diversify Away From AI
 
A difficult problem has an easy solution. 
 
 
Daniel Sotiroff 
 
 
 
 

			Sponsor Center